Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy
Circulation Research · 24.05.2024 · 134 (11) · 1465-1482
DOI: 10.1161/circresaha.123.324136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 24.05.2024. Verfasst von Ibrahim Sultan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wihuri Research Institute (I.S., M.R., P.P., K.A.H., Y.v.W., S.A., P.S., R.K., K.A.), Faculty of Medicine, Biomedicum Helsinki, University of Helsink…. Hauptthemen laut MEDLINE: Cardiomegaly, Mice, Transgenic, Endothelial Cells, Vascular Endothelial Growth Factor B. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Preclinical studies have shown the therapeutic potential of VEGF-B (vascular endothelial growth factor B) in revascularization of the ischemic myocardium, but the associated cardiac hypertrophy and adverse side effects remain a concern. To understand the importance of endothelial proliferation and migration for the beneficial versus adverse effects of VEGF-B in the heart, we explored the cardiac effects of autocrine versus paracrine VEGF-B expression in transgenic and gene-transduced mice. METHODS: We used single-cell RNA sequencing to compare cardiac endothelial gene expression in VEGF-B transgenic mouse models. Lineage tracing was used to identify the origin of a VEGF-B-induced novel endothelial cell population and adeno-associated virus–mediated gene delivery to compare the effects of VEGF-B isoforms. Cardiac function was investigated using echocardiography, magnetic resonance imaging, and micro-computed tomography. RESULTS: Unlike in physiological cardiac hypertrophy driven by a cardiomyocyte-specific VEGF-B transgene (myosin heavy chain alpha-VEGF-B), autocrine VEGF-B expression in cardiac endothelium (aP2 [adipocyte protein 2]-VEGF-B) was associated with septal defects and failure to increase perfused subendocardial capillaries postnatally. Paracrine VEGF-B led to robust proliferation and myocardial migration of a novel cardiac endothelial cell lineage (VEGF-B-induced endothelial cells) of endocardial origin, whereas autocrine VEGF-B increased proliferation of VEGF-B-induced endothelial cells but failed to promote their migration and efficient contribution to myocardial capillaries. The surviving aP2-VEGF-B offspring showed an altered ratio of secreted VEGF-B isoforms and developed massive pathological cardiac hypertrophy with a distinct cardiac vessel pattern. In the normal heart, we found a small VEGF-B-induced endothelial cell population that was only minimally expanded during myocardial infarction but not during physiological cardiac hypertrophy associated with mouse pregnancy. CONCLUSIONS: Paracrine and autocrine secretions of VEGF-B induce expansion of a specific endocardium-derived endothelial cell population with distinct angiogenic markers. However, autocrine VEGF-B signaling fails to promote VEGF-B-induced endothelial cell migration and contribution to myocardial capillaries, predisposing to septal defects and inducing a mismatch between angiogenesis and myocardial growth, which results in pathological cardiac hypertrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wihuri Research Institute (I.S., M.R., P.P., K.A.H., Y.v.W., S.A., P.S., R.K., K.A.), Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Finland.
- Translational Cancer Medicine Program (I.S., M.R., P.P., K.A.H., Y.v.W., S.A., P.S., K.A.), Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Finland.
- Institute of Pharmacology and Toxicology, Technical University of Munich, DZHK partner site Munich Heart Alliance, Germany (D.R., S.E.).
- RNATICS GmbH, Planegg, Germany (D.R.).
- A.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland (A.T., S.Y.-H.).
- Oulu Center for Cell-Matrix Research, Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Finland (L.E.).
ORCID-Profile: Ibrahim Sultan, Markus Ramste, Pim Peletier, Karthik Amudhala Hemanthakumar, Deepak Ramanujam, Ylva von Wright, Salli Antila, Pipsa Saharinen, Lauri Eklund, Seppo Ylä-Herttuala, Stefan Engelhardt, Riikka Kivelä, Kari Alitalo
Zitieren
APA
Sultan, I., Ramste, M., Peletier, P., Hemanthakumar, K. A., Ramanujam, D., Tirronen, A., von Wright, Y., Antila, S., Saharinen, P., Eklund, L., Mervaala, E., Ylä-Herttuala, S., Engelhardt, S., Kivelä, R., & Alitalo, K. (2024). Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy. Circulation Research, 134(11), 1465-1482. https://doi.org/10.1161/circresaha.123.324136
Vancouver
Sultan I, Ramste M, Peletier P, Hemanthakumar KA, Ramanujam D, Tirronen A, et al. Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy. Circulation Research. 2024;134(11):1465-1482. doi:10.1161/circresaha.123.324136
BibTeX
@article{Sultan2024,
author = {Sultan, Ibrahim and Ramste, Markus and Peletier, Pim and Hemanthakumar, Karthik Amudhala and Ramanujam, Deepak and Tirronen, Annakaisa and von Wright, Ylva and Antila, Salli and Saharinen, Pipsa and Eklund, Lauri and Mervaala, Eero and Ylä-Herttuala, Seppo and Engelhardt, Stefan and Kivelä, Riikka and Alitalo, Kari},
title = {Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy},
journal = {Circulation Research},
year = {2024},
volume = {134},
number = {11},
pages = {1465--1482},
doi = {10.1161/circresaha.123.324136}
}
EUVIMED